Join the 200th Anniversary Celebration

Original Article

Risk Factors for Hip Fracture in Black Women

Jeane Ann Grisso, Jennifer L. Kelsey, Brian L. Strom, Linda A. O'Brien, Greg Maislin, Karin LaPann, Lisa Samelson, Susie Hoffman, and the Northeast Hip Fracture Study Group

N Engl J Med 1994; 330:1555-1559June 2, 1994

Abstract

Background

Although more than 1 percent of black women 80 years of age or older have hip fractures each year, little is known about risk factors for hip fracture in these women.

Methods

We carried out a case-control study involving 144 black women admitted with a first hip fracture to 1 of 30 hospitals in New York and Philadelphia. The controls were 218 black women living in the community who were matched to the case patients according to age and ZIP Code or telephone exchange and 181 hospitalized black women matched according to age and hospital. Information was obtained through personal interviews and was studied by multivariable logistic-regression analysis.

Results

When the case patients were compared with the control subjects from the community, the women in the lowest quintile for body-mass index had a markedly increased risk of hip fracture as compared with the women in the highest quintile (odds ratio, 13.5; 95 percent confidence interval, 4.2 to 43.3). Postmenopausal estrogen therapy for one year or more was protective for women under 75 years of age (odds ratio, 0.1; 95 percent confidence interval, <0.1 to 0.5). Factors associated with an increased risk of hip fracture included a history of stroke (odds ratio, 3.1; 95 percent confidence interval, 1.2 to 8.1), use of aids in walking (odds ratio, 5.6; 95 percent confidence interval, 2.7 to 11.5), and consumption of seven or more alcoholic drinks per week (odds ratio, 4.6; 95 percent confidence interval, 1.5 to 14.1). The results were similar when the case patients were compared with the hospitalized control subjects.

Conclusions

Among black women thinness, previous stroke, use of aids in walking, and alcohol consumption are associated with an increased risk of hip fracture. Postmenopausal estrogen therapy protects against hip fracture in women under 75 years of age.

Media in This Article

Table 1Characteristics of Black Women with Hip Fractures and of Community and Hospital Controls.
Table 2Distribution of Selected Variables in Black Women with Hip Fractures and in Community Controls.
Article

Although age-specific incidence rates for hip fracture in black women are about half those in white women,1,2 the rates in black women are still considerable. Moreover, the impact of hip fracture is particularly devastating, because the rates of mortality and disability after fracture are higher among black women than among white women3,4. Although we are unaware of any comprehensive studies of risk factors for hip fracture in black women, increased bone mass in black as compared with white women may partly explain the reduced incidence of hip fracture among black women5-8. The reason for the racial differences in bone mass is not known, although studies have explored differences in hormone concentrations, calcium metabolism, body mass, and body composition5-8. The purpose of this case-control study was to identify risk factors for hip fracture in black women.

Methods

Study Design and Subjects

The case patients were black women 45 years of age or older with a radiologically confirmed diagnosis of a first hip fracture who were admitted to 1 of 30 participating hospitals in New York City or Philadelphia between September 1987 and August 1992. The results of a parallel study of white women have been published previously9-11. The study protocol was approved by the institutional review committee at each hospital, and all the study subjects gave written informed consent.

Of 315 women eligible as case patients, 221 (70 percent) participated in the study, 67 (21 percent) declined to participate, 7 (2 percent) had physicians who declined on their behalf, and 20 (6 percent) could not be followed after discharge from the hospital or were patients for whom a proxy respondent was needed but not available. A median of 11 days elapsed between admission to the hospital and the time of the study interview.

The results in the case patients were compared with the results in two control groups, a group of black women living in the community (community controls) and a group of black women who were hospitalized (hospital controls).

The community control subjects were recruited from randomly selected lists of Medicare recipients generated by the Health Care Financing Administration12 (for matching with case patients 65 years of age or older) and by telephone through random-digit dialing (for matching with case patients less than 65 years of age). The community controls were matched to the case patients according to 10-year age group and either ZIP Code or telephone exchange. No community controls were recruited for five case patients who were less than 65 years of age and did not live in a household with a telephone. In the comparison of case patients with community controls, these five case patients were excluded. Of 431 eligible community controls, 236 (55 percent) were interviewed, 157 (36 percent) declined to participate, 27 (6 percent) could not be contacted, and 11 (3 percent) required a proxy respondent but none was available.

The hospital control subjects were matched to the case patients according to 10-year age group and hospital. Of 354 eligible hospital controls, 218 (62 percent) were interviewed, 63 (18 percent) declined to participate, 49 (14 percent) had physicians who declined on their behalf, 14 (4 percent) could not be followed after discharge from the hospital, and 10 (3 percent) required a proxy respondent but none was available.

Proxy respondents were interviewed when the women were medically incapacitated or cognitively impaired. Cognitive impairment was considered to be present when a woman scored four or more errors on a modified Kahn-Goldfarb Mini-Mental Status Examination13. Proxy respondents were interviewed on behalf of 77 case patients, 37 hospital controls, and 18 community controls. The remaining 144, 181, and 218 women in the respective groups formed the basis of this analysis.

Data Collection

All the interviews were conducted in person, except for 16 proxy interviews that were conducted by telephone.

Alcohol and Smoking

Alcohol consumption was assessed by asking the women about their consumption during the past year and the usual frequency of consumption during their adult years. The number of alcoholic drinks consumed per week was classified as follows: grade 1, one or less; grade 2, two to six; and grade 3, seven or more14. A smoker was defined as a person who smoked at least one cigarette per day for six months or more. The average number of cigarettes smoked per day and the duration of smoking were also determined.

Medications

Information was obtained on the frequency and duration of any estrogen, progestin, or thiazide diuretic therapy and the age at which the therapy began. The women were also asked about any treatment with anxiolytic, hypnotic, antidepressant, or antipsychotic drugs during the past month. Psychotropic medications were classified as long-acting if they had half-lives of 24 hours or more, as specified in the American Medical Association's Drug Evaluations, fifth edition15.

Adjusted Weight

The women's estimates of their current height (in meters) and weight (in kilograms) were used to calculate the body-mass index,16 which is the weight in kilograms divided by the square of the height in meters. The women were also asked their weight at 25 years of age.

Lower-Limb Function before the Fracture

The women were asked whether they needed assistance in performing four activities related to lower-limb function: walking across a small room, getting out of a chair, walking outside on level ground, and walking up or down stairs. Their scores were calculated as the number of tasks for which assistance was needed. Women totally confined to a bed or chair were given a score of 5. The degree of physical impairment was determined separately by assessing the use of ambulatory aids, such as a cane or walker.

Visual Impairment

The women were asked whether they had glaucoma or cataracts. Those who reported that they could not see well enough (with their eyeglasses or contact lenses) to recognize a friend across the room were classified as visually impaired.

Neurologic Disease

The women were asked whether they had a history of Parkinson's disease, stroke, or epilepsy.

Proxy Questionnaire

Because of concern about potentially inaccurate reporting, the questionnaire given to the proxy respondents excluded items on the duration of smoking, the duration of therapy with thiazide diuretics or psychotropic drugs, and postmenopausal estrogen therapy. In addition, no information was obtained from the proxy respondents about the women's past use of alcohol or their current or former height and weight.

Statistical Analysis

Odds ratios and 95 percent confidence intervals were used to estimate relative risks, with conditional logistic-regression analysis because of the large number of strata that resulted from matching17,18. The initial analyses controlled for the effects of the study design (age group and ZIP Code, telephone exchange, or hospital) and also included age as a continuous variable. The final multivariable models included all statistically significant variables, as well as those whose removal substantially changed the estimates of the effect of other factors.

The relation between body-mass index and the risk of hip fracture was assessed by fitting polynomials of increasing order. On the basis of the proportional increase in value of the maximum-likelihood function, a model containing both linear and quadratic terms best described the relation. Thus, multivariable models include terms for both body-mass index and body-mass index squared.

We assessed whether there was a difference in the odds ratio between the subjects interviewed directly and those for whom a proxy was required, by obtaining separate estimates and comparing them. Because the magnitude and direction of the odds ratios did not differ substantially and no interaction with proxy status was detected, only the results from the direct interviews are presented here, since they contained more complete information.

Analyses were conducted in which the case patients were compared with both the community and the hospital controls. Detailed results are presented only for the comparison with the community controls, because the results of the two analyses were similar, and we thought that for most variables the community controls provided a more appropriate comparison group than the hospital controls.

Results

The characteristics of the case patients and control subjects who were interviewed directly are shown in Table 1Table 1Characteristics of Black Women with Hip Fractures and of Community and Hospital Controls.. Over half the case patients were 75 years old or older. There were no significant differences between the case patients and the control subjects with regard to age, years of education, or marital status.

Comparison of Case Patients and Community Controls

Table 2Table 2Distribution of Selected Variables in Black Women with Hip Fractures and in Community Controls. shows the odds ratios for the variables identified in other studies19-25 as possible risk factors or protective factors for hip fracture in white women. Women in the lowest quintile for body-mass index ( ≤ 22.6) had a greatly increased risk of hip fracture as compared with women in the heaviest quintile (body-mass index, ≥ 31.6) (odds ratio, 5.6; 95 percent confidence interval, 2.3 to 13.8). No association was found between the risk of hip fracture and body-mass index at 25 years of age as recalled by the women. Sixty-seven percent of the control subjects reported that their current weight was more than 4.5 kg greater than their weight at the age of 25, as compared with 40 percent of the case patients (odds ratio, 0.5; 95 percent confidence interval, 0.3 to 0.9). In contrast, 34 percent of the case patients reported a net loss of 4.5 kg or more as compared with only 13 percent of the control subjects (odds ratio, 2.6; 95 percent confidence interval, 1.2 to 6.0). The effect of weight loss was independent of the number of chronic illnesses.

Few women reported previous estrogen therapy for one year or more. Nevertheless, there was a protective effect that declined with age (P = 0.03). Among those who reported ever having taken estrogen, the median duration of therapy in the control group was 36 months as compared with 6 months in the case group (P = 0.04). The median age of the women at the initiation of estrogen therapy differed little between case patients and control subjects (43 and 48 years, respectively). Estrogen therapy within the past five years and therapy for seven or more years were both protective.

Current consumption of seven or more drinks per week containing alcohol was associated with an increased risk of hip fracture as compared with consumption of one drink or less per week. Women who reported decreasing their alcohol consumption from a former level of seven or more drinks per week did not have an increased risk of hip fracture as compared with those who reported always consuming little or no alcohol.

Thiazide diuretic therapy was commonly used by these women. This therapy had no significant protective effect after adjustment for body-mass index (odds ratio, 0.8; 95 percent confidence interval, 0.5 to 1.6). Regardless of their status as case patients or control subjects, heavy women (body-mass index, ≥ 31.6) were more likely to have taken a thiazide diuretic (34 percent) than thin women (body-mass index, ≤ 22.6) (16 percent; P = 0.01). Factors not associated with hip fracture included cigarette-smoking status, parity, and age at menopause.

Several variables were assessed that have been identified as risk factors for falls. An increased risk of hip fracture was associated with a previous stroke, the use of ambulatory aids, lower-limb dysfunction, and a diagnosis of epilepsy (Table 2). There was a possibly increased risk associated with therapy with long-acting psychotropic drugs (odds ratio, 2.8; 95 percent confidence interval, 0.8 to 9.4), but not with short-acting ones. We compared the characteristics of falls in the case patients with those in a subgroup of 29 control subjects who reported a fall in the past six months that did not result in a fracture. The control subjects who had fallen recently were more likely to have landed on a soft surface (39 percent) than the case patients (22 percent; P = 0.02), although there was no difference in the height of the falls.

We constructed a multivariable conditional logistic-regression model, retaining factors that were independent predictors of hip fracture and factors whose removal substantially altered the effect of one or more of the other factors (Table 3Table 3Multivariable Analysis of Risk Factors for Hip Fractures in Black Women.). The independent predictors included body-mass index, estrogen therapy, use of ambulatory aids, alcohol consumption, and history of stroke.

Comparison of Case Patients and Hospital Controls

We compared the case patients and the hospital controls with respect to the variables shown in Table 3. The results were similar, although the strength of the associations varied slightly from those in the comparison with the community controls. Body-mass index was defined in quintiles based on the distribution in the hospital controls. Women in the lowest quintile ( ≤ 22.6) had an increased risk of hip fracture as compared with women in the heaviest quintile ( ≥ 31.6) (odds radio, 13.9; 95 percent confidence interval, 4.4 to 44.1); a history of stroke (odds ratio, 2.2; 95 percent confidence interval, 0.8 to 5.6), use of ambulatory aids (odds ratio, 2.4; 95 percent confidence interval, 1.2 to 4.9), and current consumption of seven or more alcoholic drinks per week (odds ratio, 4.0; 95 percent confidence interval, 1.0 to 15.8) were all associated with an increased risk of hip fracture. There was also a trend toward a protective effect of estrogen therapy lasting one year or more (odds ratio, 0.3; 95 percent confidence interval, 0.1 to 1.3).

Discussion

A number of important risk factors for hip fracture emerged in this study of black women. Thinner women were at substantially higher risk for hip fracture than their heavier counterparts, a finding consistent with those of studies of white women19-21 and a previous study of black women22. The protective effect of increased body mass appears to result primarily from weight gained since the early adult years, not from having been heavy in early adulthood. The protection due to increased body mass has been postulated to be a result of increased adipose-based production of estrogen, greater gravitational forces on bone mass, and increased padding around the hips that may decrease the transmission of energy from the impact of the fall to the proximal femur5,19,23. Although 95 percent of hip fractures in the women in these studies occurred as a result of a fall, no information was collected about the site of impact or the distribution of body fat.

Estrogen therapy had a protective effect on women under the age of 75 years, as has also been reported for white women24-27. Few women reported taking estrogens (8 percent of the control subjects), although there was a rather high rate of hysterectomy (33 percent). Although the power of the study to evaluate estrogen therapy in detail was limited, our results are consistent with the hypothesis that there is a protective effect of recent use and of prolonged therapy27.

We found no protective effect of thiazide diuretic drugs, which many women reported taking. The latter were not found to protect against hip fracture. Whether thiazides offer such protection is a particularly important question for black women, given the high prevalence of hypertension in this group28. Among white women, some studies have reported a protective effect of thiazides, but most did not control for body mass29-31.

We found an increased risk of hip fracture in women who reported consuming seven or more alcoholic drinks per week as compared with those who reported minimal or no consumption of alcohol. This association has not been reported consistently in white women19,20. The association between alcohol consumption and the risk of hip fracture was independent of body weight, the number of chronic illnesses, and cigarette smoking and was limited to current consumption. These results are consistent with those reported by the Framingham Study, in which heavy current, but not former, consumption of alcohol was associated with an increased risk of hip fracture14. This may indicate that alcohol consumption increases the risk of hip fracture by increasing the risk of falls.

As we found in our earlier study of white women,5 risk factors for falls (e.g., previous stroke and the use of ambulatory aids) were important independent predictors of hip fracture in black women.

Some limitations of the present study should be mentioned. As compared with studies of younger persons, it may seem to have a low response rate (70 percent of case patients, 62 percent of hospital controls, and 55 percent of community controls). However, very old women (median age, 76 years) participated, and lower response rates are common in studies of persons in this age group32,33. Because some women with severe cognitive impairment were excluded and certain factors could not be assessed accurately in proxy interviews, the results of this study cannot be generally applied to women with severe cognitive impairment. It was not possible to validate the information reported by the subjects. Finally, several potential risk factors were not assessed, such as exposure to sunlight, vitamin D intake, and thyroid hormone therapy.

In conclusion, a major determinant of the risk of hip fracture in black women is body mass. Given the magnitude of the association and the prevalence of obesity in black women (60 percent),34 increased body mass probably explains some of the racial differences in rates of hip fracture. Estrogen therapy may be important for the prevention of such fractures in black women. Finally, the risk factors for falls also appear to be important risk factors for hip fracture. Programs to prevent falls in black women are likely to result in a reduced incidence of hip fracture.

Supported by a grant (R01-AR35409) from the National Institutes of Health.

We are indebted to the late Ms. Christy Golden for her support of this project.

Source Information

From the Center for Clinical Epidemiology and Biostatistics, Division of General Internal Medicine, School of Medicine, University of Pennsylvania, Philadelphia (J.A.G., B.L.S., L.A.O., G.M., K.L.); the Department of Health Research and Policy, School of Medicine, Stanford University, Stanford, Calif. (J.L.K.); and the Division of Epidemiology, Columbia University, New York (L.S., S.H.). The Northeast Hip Fracture Study Group includes, in Philadelphia, Dr. James Anthony and Dr. Alan Hibberd, Mercy Catholic Medical Center; Dr. Michael Clancy, Temple University Health Sciences Center; Dr. Jerome Cotler, Jefferson University Hospital; Dr. William DeLong, Cooper Hospital/ University Medical Center; Dr. Malcolm Ecker, Chestnut Hill Hospital; Dr. Z.B. Friedenberg, Presbyterian-University of Pennsylvania Medical Center; Dr. Robert Good, Bryn Mawr Hospital; Dr. Charles Hummer, Crozer-Chester Medical Center and Sacred Heart Hospital; Dr. David Junkin, Abington Hospital; Dr. William Markman, Jeanes Hospital; Dr. Pekka Mooar, Medical College of Pennsylvania; Dr. Herbert Stein, Frankford Hospital; Dr. Milton Wohl, Albert Einstein Medical Center; Dr. Brendan Wynne, Philadelphia College of Osteopathic Medicine; and Dr. Dennis Zaslow, St. Joseph's Hospital; and in New York, Dr. David Andrews, Allen Pavilion; Dr. Harold Dick, Columbia-Presbyterian Medical Center; Dr. Edward Habermann, Montefiore Medical Center; Dr. Harvey Insler, Bronx-Lebanon Hospital Center; Dr. Placido Menezes, Interfaith Medical Center; Dr. Ronald Rosenthal, Long Island Jewish Medical Center; Dr. Arthur Sadler, Jacobi Hospital; Dr. Marvin Shelton, Harlem Hospital; Dr. Joel Teicher, Brookdale Hospital Medical Center; and Dr. Robert Zickel, St. Luke's-Roosevelt Hospital Center.

Address reprint requests to Dr. Grisso at the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, 317R Nursing Education Bldg., 420 Service Dr., Philadelphia, PA 19104-6095.

References

References

  1. 1

    Farmer ME, White LR, Broday JA, Bailey KR. Race and sex differences in hip fracture incidence. Am J Public Health 1984;74:1374-1380
    CrossRef | Web of Science | Medline

  2. 2

    Kellie SE, Brody JA. Sex-specific and race-specific hip fracture rates. Am J Public Health 1990;80:326-328
    CrossRef | Web of Science | Medline

  3. 3

    Furstenberg AL, Mezey MD. Differences in outcome between black and white elderly hip fracture patients. J Chronic Dis 1987;40:931-938
    CrossRef | Medline

  4. 4

    Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Survival experience of aged hip fracture patients. Am J Public Health 1989;79:274-278
    CrossRef | Web of Science | Medline

  5. 5

    Meier DE, Luckey MM, Wallenstein S, Lapinski RH, Catherwood B. Racial differences in pre- and postmenopausal bone homeostasis: association with bone density. J Bone Miner Res 1992;7:1181-1189
    CrossRef | Web of Science | Medline

  6. 6

    Ortiz O, Russell M, Daley TL, et al. Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition. Am J Clin Nutr 1992;55:8-13
    Web of Science | Medline

  7. 7

    Dawson-Hughes B, Harris S, Kramich C, Dallal G, Rasmussen HM. Calcium retention and hormone levels in black and white women on high- and low-calcium diets. J Bone Miner Res 1993;8:779-787
    CrossRef | Web of Science | Medline

  8. 8

    Bell NH, Yergey AL, Vieira NE, Oexmann MJ, Shary JR. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J Bone Miner Res 1993;8:1111-1115
    CrossRef | Web of Science | Medline

  9. 9

    Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326-1331
    Full Text | Web of Science | Medline

  10. 10

    Nieves JW, Grisso JA, Kelsey JL. A case-control study of hip fracture: evaluation of selected dietary variables and teenage physical activity. Osteoporos Int 1992;2:122-127
    CrossRef | Web of Science | Medline

  11. 11

    Hoffman S, Grisso JA, Kelsey JL, Gammon MD, O'Brien LA. Parity, lactation and hip fracture. Osteoporos Int 1993;3:171-176
    CrossRef | Web of Science | Medline

  12. 12

    Hatten J. Medicare's common denominator: the covered population. Health Care Financ Rev 1980;2:53-64
    Medline

  13. 13

    Kahn RL, Goldfarb AI, Pollack M, Peck A. Brief objective measures for the determination of mental status in the aged. Am J Psychiatry 1960;117:326-328
    Web of Science | Medline

  14. 14

    Felson DT, Kiel DP, Anderson JJ, Kannel WB. Alcohol consumption and hip fractures: the Framingham Study. Am J Epidemiol 1988;128:1102-1110
    Web of Science | Medline

  15. 15

    American Medical Association, Department of Drugs. AMA drug evaluations. 5th ed. Chicago: American Medical Association, 1983.

  16. 16

    Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes 1985;9:147-153
    Web of Science | Medline

  17. 17

    Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning, 1982.

  18. 18

    Gail MH, Lubin JH, Rubinstein LV. Likelihood calculations for matched case-control studies and survival studies with tied death times. Biometrika 1981;68:703-707
    CrossRef | Web of Science

  19. 19

    Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178-208
    Web of Science | Medline

  20. 20

    Kelsey JL, Hoffman S. Risk factors for hip fracture. N Engl J Med 1987;316:404-406
    Full Text | Web of Science | Medline

  21. 21

    Farmer ME, Harris T, Madans JH, et al. Anthropometric indicators and hip fracture: the NHANES I epidemiologic follow-up study. J Am Geriatr Soc 1989;37:9-16
    Web of Science | Medline

  22. 22

    Pruzansky ME, Turano M, Luckey M, Senie R. Low body weight as a risk factor for hip fracture in both black and white women. J Orthop Res 1989;7:192-197
    CrossRef | Web of Science | Medline

  23. 23

    Cummings SR, Nevitt MC. A hypothesis: the causes of hip fractures. J Gerontol 1989;44:M107-M111
    Medline

  24. 24

    Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980;303:1195-1198
    Full Text | Web of Science | Medline

  25. 25

    Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985;102:319-324
    Web of Science | Medline

  26. 26

    Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women: the Framingham Study. N Engl J Med 1987;317:1169-1174
    Full Text | Web of Science | Medline

  27. 27

    Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF, Anderson JJ. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141-1146
    Full Text | Web of Science | Medline

  28. 28

    Health status of the disadvantaged: Chartbook 1990. Hyattsville, Md.: Department of Health and Human Services, 1990:77. (DHHS publication no. (HRSA) HRS-P-DV90-1).

  29. 29

    Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fracture: results from the Framingham Study. JAMA 1991;265:370-373
    CrossRef | Web of Science | Medline

  30. 30

    Ray WA, Griffin MR, Downey W, Melton LJ III. Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1989;1:687-690
    CrossRef | Web of Science | Medline

  31. 31

    Cauley JA, Cummings SR, Seeley DG, et al. Effects of thiazide diuretic therapy on bone mass, fractures, and falls. Ann Intern Med 1993;118:666-673
    Web of Science | Medline

  32. 32

    Kaye JM, Lawton P, Kaye D. Attitudes of elderly people about clinical research on aging. Gerontologist 1990;30:100-106
    CrossRef | Web of Science | Medline

  33. 33

    Herzog AR, Rodgers WL. Age and response rates to interview sample surveys. J Gerontol 1988;43:S200-S205
    Medline

  34. 34

    Kumanyika S. Obesity in black women. Epidemiol Rev 1987;9:31-50
    Web of Science | Medline

Citing Articles (53)

Citing Articles

  1. 1

    KoKo Aung, Thwe Htay, KoKo Aung. 2011. Thiazide diuretics and the risk of hip fracture. .
    CrossRef

  2. 2

    H.-F. Hwang, H.-D. Lee, H.-H. Huang, C.-Y. Chen, M.-R. Lin. (2011) Fall mechanisms, bone strength, and hip fractures in elderly men and women in Taiwan. Osteoporosis International 22:8, 2385-2393
    CrossRef

  3. 3

    Hans P. Dimai, Manju Chandran. (2011) Official Positions for FRAX® Clinical Regarding Smoking. Journal of Clinical Densitometry 14:3, 190-193
    CrossRef

  4. 4

    Ray Marks. (2011) Physical Activity and Hip Fracture Disability: A Review. Journal of Aging Research 2011, 1-18
    CrossRef

  5. 5

    Yuan Chen, Hui Shen, Fang Yang, Peng-Yuan Liu, Nelson Tang, Robert R. Recker, Hong-Wen Deng. (2009) Choice of study phenotype in osteoporosis genetic research. Journal of Bone and Mineral Metabolism 27:2, 121-126
    CrossRef

  6. 6

    M. Goffredo, M. Schmid, S. Conforto, M. Carli, A. Neri, T. D'Alessio. (2009) Markerless Human Motion Analysis in Gauss–Laguerre Transform Domain: An Application to Sit-To-Stand in Young and Elderly People. IEEE Transactions on Information Technology in Biomedicine 13:2, 207-216
    CrossRef

  7. 7

    Anne M. Kenny, JoAnne Smith, Emre Noteroglu, Ilana Y. Waynik, Cynthia Ellis, Alison Kleppinger, Kristen Annis, Debrorah Dauser, Stephen Walsh. (2009) Osteoporosis Risk in Frail Older Adults in Assisted Living. Journal of the American Geriatrics Society 57:1, 76-81
    CrossRef

  8. 8

    Karina M. Berg, Hillary V. Kunins, Jeffrey L. Jackson, Shadi Nahvi, Amina Chaudhry, Kenneth A. Harris, Rubina Malik, Julia H. Arnsten. (2008) Association Between Alcohol Consumption and Both Osteoporotic Fracture and Bone Density. The American Journal of Medicine 121:5, 406-418
    CrossRef

  9. 9

    Jane A Cauley, LieLing Wu, Nina S Wampler, Janice M Barnhart, Matthew Allison, Zhao Chen, Rebecca Jackson, John Robbins. (2007) Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative. Journal of Bone and Mineral Research 22:11, 1816-1826
    CrossRef

  10. 10

    Joan M. Neuner, Xu Zhang, Rodney Sparapani, Purushottam W. Laud, Ann B. Nattinger. (2007) Racial and Socioeconomic Disparities in Bone Density Testing Before and After Hip Fracture. Journal of General Internal Medicine 22:9, 1239-1245
    CrossRef

  11. 11

    Gillian C Hall, Alex D McMahon. (2007) Comparative study of modified release alpha-blocker exposure in elderly patients with fractures. Pharmacoepidemiology and Drug Safety 16:8, 901-907
    CrossRef

  12. 12

    K. J. Mukamal, J. A. Robbins, J. A. Cauley, L. M. Kern, D. S. Siscovick. (2007) Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study. Osteoporosis International 18:5, 593-602
    CrossRef

  13. 13

    Lee S. Simon. (2007) Osteoporosis. Rheumatic Disease Clinics of North America 33:1, 149-176
    CrossRef

  14. 14

    Tamara J. Vokes, Daniel L. Gillen, Ann T. Pham, Jeanne M. Lovett. (2007) Risk Factors for Prevalent Vertebral Fractures in Black and White Female Densitometry Patients. Journal of Clinical Densitometry 10:1, 1-9
    CrossRef

  15. 15

    Farid Abolhassani, Alireza Moayyeri, Mohsen Naghavi, Akbar Soltani, Bagher Larijani, Hamidreza Tavakoli Shalmani. (2006) Incidence and characteristics of falls leading to hip fracture in Iranian population. Bone 39:2, 408-413
    CrossRef

  16. 16

    Elizabeth J. Samelson, Marian T. Hannan. (2006) Epidemiology of osteoporosis. Current Rheumatology Reports 8:1, 76-83
    CrossRef

  17. 17

    Jane A. Cauley, Robin L. Fullman, Katie L. Stone, Joseph M. Zmuda, Douglas C. Bauer, Elizabeth Barrett-Connor, Kristine Ensrud, Edith M. C. Lau, Eric S. Orwoll, . (2005) Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporosis International 16:12, 1525-1537
    CrossRef

  18. 18

    Annlia Paganini-Hill, Kathryn A. Atchison, Jeffery A. Gornbein, Aurelia Nattiv, Susan K. Service, Stuart C. White. (2005) Menstrual and Reproductive Factors and Fracture Risk: The Leisure World Cohort Study. Journal of Women's Health 14:9, 808-819
    CrossRef

  19. 19

    Redonda G. Miller, Bimal H. Ashar, Jennifer Cohen, Melissa Camp, Carmen Coombs, Elizabeth Johnson, Christine R. Schneyer. (2005) Disparities in Osteoporosis Screening Between At-Risk African-American and White Women. Journal of General Internal Medicine 20:9, 847-851
    CrossRef

  20. 20

    Christine G. Unson, Richard Fortinsky, Karen Prestwood, Susan Reisine. (2005) Osteoporosis Medications Used by Older African–American Women: Effects of Socioeconomic Status and Psychosocial Factors. Journal of Community Health 30:4, 281-297
    CrossRef

  21. 21

    Terence J. Aspray, Liya Yan, Ann Prentice. (2005) Parathyroid hormone and rates of bone formation are raised in perimenopausal rural Gambian women. Bone 36:4, 710-720
    CrossRef

  22. 22

    Grattan C. Woodson. (2004) Risk factors for osteoporosis. Current Medical Research and Opinion 20:10, 1681-1687
    CrossRef

  23. 23

    Michael R. Cooley, Kenneth J. Koval. (2004) Hip Fracture. Techniques in Orthopaedics 19:3, 104-114
    CrossRef

  24. 24

    Ranuccio Nuti, Giuseppe Martini, Roberto Valenti, Dario Gambera, Luigi Gennari, Stefania Salvadori, Annalisa Avanzati. (2004) Vitamin D Status and Bone Turnover in Women with Acute Hip Fracture. Clinical Orthopaedics and Related Research 422, 208-213
    CrossRef

  25. 25

    Yong Zhang, Kiyoshi Aoyagi, Sumihisa Honda, Yuichiro Yahata, Itsuro Yoshimi, Yosuke Kusano, Noboru Takamura, Minatsu Kobayashi, Kazuhiko Moji, Tai-ichiro Takemoto. (2003) Effects of Lifestyle Factors on Stiffness Index of Calcaneus Measured by Quantitative Ultrasound Systemamong Japanese Women Aged 40 Years and Over: The Hizen-Oshima Study. The Tohoku Journal of Experimental Medicine 201:2, 97-107
    CrossRef

  26. 26

    Robert G Cumming, David G Le Couteur. (2003) Benzodiazepines and Risk of Hip Fractures in Older People. CNS Drugs 17:11, 825-837
    CrossRef

  27. 27

    Ray Marks, John P Allegrante, C Ronald MacKenzie, Joseph M Lane. (2003) Hip fractures among the elderly: causes, consequences and control. Ageing Research Reviews 2:1, 57-93
    CrossRef

  28. 28

    M. Carrington Reid, Nashaat N. Boutros, Patrick G. O'Connor, Arina Cadariu, John Concato. (2002) The health‐related effects of alcohol use in older persons: A systematic review. Substance Abuse 23:3, 149-164
    CrossRef

  29. 29

    Z. Yuan, N. Dawson, G. S. Cooper, D. Einstadter, R. Cebul, A. A. Rimm. (2001) Effects of alcohol-related disease on hip fracture and mortality: a retrospective cohort study of hospitalized Medicare beneficiaries. American Journal of Public Health 91:7, 1089-1093
    CrossRef

  30. 30

    P. Fitzpatrick, P. N. Kirke, L. Daly, I. Rooij, E. Dinn, H. Burke, J. Heneghan, G. Bourke, J. Masterson. (2001) Predictors of first hip fracture and mortality post fracture in older women. Irish Journal of Medical Science 170:1, 49-53
    CrossRef

  31. 31

    Catherine O. Stehman-Breen, Donald J. Sherrard, Astier M. Alem, Daniel L. Gillen, Susan R. Heckbert, Craig S. Wong, Adrianne Ball, Noel S. Weiss. (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney International 58:5, 2200-2205
    CrossRef

  32. 32

    Cynthia Henderson, Maria Fiatarone Singh. 2000. Minority Women’s Health. , 329-342.
    CrossRef

  33. 33

    Bahman Y. Farahmand, Karl Michaëlsson, John A. Baron, Per-Gunnar Persson, Sverker Ljunghall. (2000) Body Size and Hip Fracture Risk. Epidemiology 11:2, 214-219
    CrossRef

  34. 34

    M.Carrington Reid, I.M. Voynick, P. Peduzzi, D.A. Fiellin, M.E. Tinetti, J. Concato. (2000) Alcohol exposure and health services utilization in older veterans. Journal of Clinical Epidemiology 53:1, 87-93
    CrossRef

  35. 35

    ARLINE D. BOHANNON. (1999) Osteoporosis and African American Women. Journal of Women's Health & Gender-Based Medicine 8:5, 609-615
    CrossRef

  36. 36

    Robert L. Satcher. (1999) African Americans and Orthopaedic Surgery. Clinical Orthopaedics and Related Research 362, 114???116
    CrossRef

  37. 37

    Håkan Melhus, Karl Michaëlsson, Lars Holmberg, Alicja Wolk, Sverker Ljunghall. (1999) Smoking, Antioxidant Vitamins, and the Risk of Hip Fracture. Journal of Bone and Mineral Research 14:1, 129-135
    CrossRef

  38. 38

    Katharine A. Bradley, Seeta Badrinath, Kristen Bush, Jodie Boyd-Wickizer, Bradley Anawalt. (1998) Medical Risks for Women Who Drink Alcohol. Journal of General Internal Medicine 13:9, 627-639
    CrossRef

  39. 39

    WENDY L. ADAMS, THOMAS V. JONES. (1998) Alcohol and injuries in elderly people. Addiction Biology 3:3, 237-247
    CrossRef

  40. 40

    Michael E. Mussolino, Anne C. Looker, Jennifer H. Madans, Jean A. Langlois, Eric S. Orwoll. (1998) Risk Factors for Hip Fracture in White Men: The NHANES I Epidemiologic Follow-up Study. Journal of Bone and Mineral Research 13:6, 918-924
    CrossRef

  41. 41

    John A. Eisman. (1998) Genetics, calcium intake and osteoporosis. Proceedings of the Nutrition Society 57:02, 187-193
    CrossRef

  42. 42

    John A. Eisman. (1998) Vitamin D Polymorphisms and Calcium Homeostasis: A New Concept of Normal Gene Variants and Physiologic Variation. Nutrition Reviews 56, S22-S29
    CrossRef

  43. 43

    Ross E. Andersen, Thomas A. Wadden, Richard J. Herzog. (1997) Changes in bone mineral content in obese dieting women. Metabolism 46:8, 857-861
    CrossRef

  44. 44

    Saeko Fujiwara, Fumiyoshi Kasagi, Michiko Yamada, Kazunori Kodama. (1997) Risk Factors for Hip Fracture in a Japanese Cohort. Journal of Bone and Mineral Research 12:7, 998-1004
    CrossRef

  45. 45

    M. Carrington Reid, Philip A. Anderson. (1997) GERIATRIC SUBSTANCE USE DISORDERS. Medical Clinics of North America 81:4, 999-1016
    CrossRef

  46. 46

    KAREN L. MILLER. (1996) Hormone Replacement Therapy in the Elderly. Clinical Obstetrics and Gynecology 39:4, 912-932
    CrossRef

  47. 47

    J. F. Aloia, A. Vaswani, J. K. Yeh, E. Flaster. (1996) Risk for osteoporosis in black women. Calcified Tissue International 59:6, 415-423
    CrossRef

  48. 48

    Fabio Parazzini, Alessandra Tavani, Elena Ricci, Carlo La Vecchia. (1996) Menstrual and reproductive factors and hip fractures in post menopausal women. Maturitas 24:3, 191-196
    CrossRef

  49. 49

    Fabio Parazzini, Alessandra Tavani, Elena Ricci, Carlo La Vecchia. (1996) Menstrual and reproductive factors and hip fractures in post menopausal women. Maturitas 24:6, 191-196
    CrossRef

  50. 50

    John A Eisman. (1996) Vitamin D receptor gene variants: implicatiosn for therapy. Current Opinion in Genetics & Development 6:3, 361-365
    CrossRef

  51. 51

    W.C. Hayes, E.R. Myers, S.N. Robinovitch, A. Van Den Kroonenberg, A.C. Courtney, T.A. McMahon. (1996) Etiology and prevention of age-related hip fractures. Bone 18:1, S77-S86
    CrossRef

  52. 52

    Marie Luz Villa, Robert Marcus, Romelia Ramírez Delay, Jennifer L. Kelsey. (1995) Factors contributing to skeletal health of postmenopausal Mexican-American women. Journal of Bone and Mineral Research 10:8, 1233-1242
    CrossRef

  53. 53

    Cummings, Steven R., Nevitt, Michael C., Browner, Warren S., Stone, Katie, Fox, Kathleen M., Ensrud, Kristine E., Cauley, Jane, Black, Dennis, Vogt, Thomas M., . (1995) Risk Factors for Hip Fracture in White Women. New England Journal of Medicine 332:12, 767-774
    Full Text